Correlation Between ImmuPharma PLC and Bytes Technology

Can any of the company-specific risk be diversified away by investing in both ImmuPharma PLC and Bytes Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuPharma PLC and Bytes Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ImmuPharma PLC and Bytes Technology, you can compare the effects of market volatilities on ImmuPharma PLC and Bytes Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuPharma PLC with a short position of Bytes Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuPharma PLC and Bytes Technology.

Diversification Opportunities for ImmuPharma PLC and Bytes Technology

-0.18

Correlation Coefficient

ImmuPharma PLC  Bytes Technology

Good diversification

The 3 months correlation between ImmuPharma and Bytes is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding ImmuPharma PLC and Bytes Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bytes Technology and ImmuPharma PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuPharma PLC are associated (or correlated) with Bytes Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bytes Technology has no effect on the direction of ImmuPharma PLC i.e., ImmuPharma PLC and Bytes Technology go up and down completely randomly.

Pair Corralation between ImmuPharma PLC and Bytes Technology

Assuming the 90 days trading horizon ImmuPharma PLC is expected to generate 13.01 times more return on investment than Bytes Technology. However, ImmuPharma PLC is 13.01 times more volatile than Bytes Technology. It trades about 0.1 of its potential returns per unit of risk. Bytes Technology is currently generating about -0.07 per unit of risk. If you would invest  194.00  in ImmuPharma PLC on October 20, 2024 and sell it today you would earn a total of  141.00  from holding ImmuPharma PLC or generate 72.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

ImmuPharma PLC  vs.  Bytes Technology

ImmuPharma PLC

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ImmuPharma PLC are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, ImmuPharma PLC exhibited solid returns over the last few months and may actually be approaching a breakup point.

Bytes Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bytes Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with ImmuPharma PLC and Bytes Technology

The main advantage of trading using opposite ImmuPharma PLC and Bytes Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuPharma PLC position performs unexpectedly, Bytes Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bytes Technology will offset losses from the drop in Bytes Technology's long position.

The idea behind ImmuPharma PLC and Bytes Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.